Michael A. Daneshvar, MD, MS

Assistant Professor of Clinical Urology
Division Chief of Urologic Oncology
Associate Director of Residency Program

Dr. Michael Daneshvar is a fellowship trained Urologic Oncologist from the National Cancer Institute (NCI)/National Institutes of Health (NIH). He specializes in both robotic and open surgery for the treatment of bladder, kidney, prostate, penile, testis, and adrenal cancer. His research interests include hereditary diseases and genomic alterations in genitourinary cancer. In addition, he is well published and has an interest in novel imaging techniques (artificial intelligence, PSMA), focal therapy and ablation of prostate cancer.

Areas of Focus

Urologic oncology (bladder, kidney, prostate, penile, testes, adrenal)

Robot-assisted & open surgery

Hereditary & genetic diseases

Clinical trials

Training (History)

Masters

Biomedical Sciences, Rosalind Franklin University of Medicine and Science

Medical School

With a Distinction in Research (MDDR), Chicago Medical School, Rosalind Franklin University of Medicine and Science

Internship & Residency

SUNY Upstate Medical University

Fellowship

Society of Urologic Oncology Fellow, Urologic Oncology Branch, National Cancer Institute/National Institutes of Health (NCI/NIH)